Performance by category
Death-per-report rate within each category, compared to the corpus-wide average for that same category. Ratio > 1 means this manufacturer's mortality is higher than the field for that category; ratio < 1 means lower.
| Category | Devices | Reports | Deaths | Death rate | Corpus avg | vs corpus |
|---|---|---|---|---|---|---|
| CSF / ICP | 364 | 19,301 | 166 | 0.86% | 0.89% | 0.97× |
| Cranial surgery | 54 | 3,284 | 7 | 0.21% | 0.38% | 0.57× |
| Spinal implants | 2 | 44 | 0 | 0.00% | 0.47% | 0.00× |
| DBS / neuromodulation | 1 | 44 | 1 | 2.27% | 1.53% | 1.49× |
Temporal trajectory
Annual reports for this manufacturer's neurosurgical devices, split by FDA event type. Use it to spot inflection points (recall responses, product launches, reporting-pattern shifts).
Failure-mode signature
Per category, this manufacturer's failure-mode mix vs other manufacturers in the SAME category — an apples-to-apples comparison that strips out the confound of "which categories they happen to operate in." Click a category tab to drill in.
Highest-mortality devices
Top 10 of this manufacturer's devices ranked by death-per-report rate (minimum 100 reports to avoid small-sample noise). Click any device for its full profile.
| Device | Category | Reports | Deaths | Death rate |
|---|---|---|---|---|
| Codman Unknown Valve/Shunt | CSF / ICP | 223 | 14 | 6.28% |
| Codman Accudrain | CSF / ICP | 107 | 5 | 4.67% |
| Codman Unknown Catheter | CSF / ICP | 209 | 6 | 2.87% |
| Codman Certas Plus Valve | CSF / ICP | 108 | 3 | 2.78% |
| Codman External Drainage System III | CSF / ICP | 147 | 4 | 2.72% |
| Codman Strata Valve/Shunt | CSF / ICP | 515 | 12 | 2.33% |
| Codman Strata | CSF / ICP | 755 | 16 | 2.12% |
| Codman Microsensor Ventricular Catheter | CSF / ICP | 243 | 3 | 1.23% |
| Codman Bactiseal | CSF / ICP | 172 | 2 | 1.16% |
| Codman Certas Plus | CSF / ICP | 192 | 2 | 1.04% |